Nippon India Pharma Fund Direct G
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct G
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 9479.08
Nippon India Pharma Fund Direct G - Nav Details
Nav Date
: 11-Sep-2026
NAV [Rs.]
: 638.3641
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct G- NAV Chart
Nippon India Pharma Fund Direct G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -0.57 | -1.39 | 6.09 | 10.78 | 10.69 | 18.55 | 13.62 | 17.52 |
| Category Avg | 0.18 | -0.26 | 9.87 | 18.47 | 16.17 | 20.65 | 14.44 | 16.88 |
| Category Best | 1.72 | 2.74 | 15.05 | 26.98 | 28.09 | 24.24 | 18.67 | 32.19 |
| Category Worst | -1.33 | -3.53 | 3.69 | 6.88 | 2.99 | 16.41 | 11.42 | -0.29 |
Nippon India Pharma Fund Direct G- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Molbio Diagnosti3,80,293
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.37 | 5906349 | 1,172.29 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 7.00 | 700754 | 663.40 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.43 | 2783991 | 609.24 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.09 | 4095054 | 577.07 |
| Equity | Apollo Hospitals | Healthcare Services | 5.15 | 548795 | 488.34 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 4.93 | 4049746 | 467.50 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.09 | 1603562 | 387.93 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.94 | 2555745 | 373.06 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.47 | 913918 | 329.18 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 3.31 | 1029460 | 313.99 |
| Equity | Max Healthcare | Healthcare Services | 2.92 | 2658082 | 276.99 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.84 | 1364742 | 269.52 |
| Equity | Vijaya Diagnost. | Healthcare Services | 2.68 | 1671618 | 253.81 |
| Equity | Medplus Health | Retailing | 2.51 | 3545229 | 238.32 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.45 | 3837967 | 232.00 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.44 | 800549 | 231.02 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 2.25 | 9937272 | 213.05 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.13 | 78126 | 201.95 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.04 | 1000578 | 193.57 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.82 | 323678 | 172.50 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.66 | 823911 | 157.13 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 1.63 | 902630 | 154.98 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.57 | 318249 | 149.08 |
| Equity | Syngene Intl. | Healthcare Services | 1.48 | 3501497 | 140.32 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.39 | 3896349 | 131.91 |
| Equity | Fortis Health. | Healthcare Services | 1.29 | 1346128 | 122.08 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.25 | 640910 | 118.90 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.20 | 1275040 | 113.86 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 1.11 | 1351672 | 104.98 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.09 | 2504071 | 103.16 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 0.99 | 300272 | 93.80 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 0.93 | 213659 | 88.45 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.47 | 1834924 | 44.65 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.46 | 62568 | 43.49 |
| Equity | Molbio Diagnosti | Healthcare Equipment & Supplies | 0.44 | 380293 | 41.31 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.17 | 111738 | 16.15 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,67,506.41
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
